| | |

Identifying New MicroRNA Tumor Biomarkers for Mesothelioma

Identifying New MicroRNA Tumor Biomarker for Mesothelioma Identifying New MicroRNA Tumor Biomarkers for Mesothelioma

Italian researchers have taken an important step forwards in what amounts to a microRNA tumor biomarker for mesothelioma.

Exposure to asbestos fibers causes malignant pleural mesothelioma. An early diagnosis and comprehensive health monitoring is vital for patients exposed to asbestos fibers. Researchers at the University of Catania in Italy say these two clinical issues “may be solved by the identification of specific biomarkers.”

A new article in Nature Scientific Reports identifies RNA molecules could serve as a microRNA signature for mesothelioma. This “signature” could help doctors distinguish mesothelioma from other types of cancer.

The Challenge of Mesothelioma Diagnosis

Pleural mesothelioma is particularly hard to diagnose. The early symptoms of mesothelioma are similar to the symptoms of many other lung conditions. They are also similar to lung cancer.

One of the symptoms of mesothelioma is pleural effusion. Lung cancer and several other types of cancer can also cause pleural effusion. As lung fluid builds up, it gets harder for patients to breathe. Often, doctors drain this fluid to help with symptoms.

Under a microscope, this fluid can help show if a patient has cancer. But it is difficult to tell if the cancer cells floating in the fluid came from a mesothelioma tumor or another kind of cancer.

That is where having a clear microRNA signature for mesothelioma could be useful. If a sample contained that unique set of markers, it could be an indication that the patient probably has mesothelioma.

In Search of a MicroRNA Tumor Biomarker for Mesothelioma

MicroRNAs are tiny non-coding bits of RNA. They play an important role in regulating gene expression inside cells, including mesothelioma cells.

MicroRNAs are well-known signposts or “biomarkers” for several types of cancer. Biomarkers offer a simple, inexpensive, and minimally invasive way to look for cancer.

But there are hundreds of microRNAs. If doctors do not know exactly which ones are linked to mesothelioma, they cannot use them to diagnose it. As Dr. Carla Loreto states, “finding potential biomarkers is a very difficult aim that provides a lot of research work.”

Interactive Mesothelioma-Based Network

In this latest report, researchers were able to compare microRNAs of normal mesothelial and malignant mesothelioma cells. This is important for finding a mesothelioma microRNA tumor biomarker and diagnosing mesothelioma earlier.

The team was able to do this by using a new interactive mesothelioma-based network. This network allowed the team to compare tumor and non-tumor samples. And they were able to analyze samples based on asbestos exposure rates.

This is the first time anyone has analyzed these molecules in the context of mesothelioma using in vitro systems.

Dr. Veronica Filetti from the Department of Biomedical and Biotechnological Sciences, University of Catania, states that “Early detection of…tumor biomarkers represents one of the most promising strategies to enhance the survival of cancer patients…”

This important work is the first step in validating a new mesothelioma biomarker. The Italian team hopes to use this method in a liquid biopsy in the future. This would provide a minimally invasive screening method for the prevention of mesothelioma.

Source

Filetti, Veronica, Alessandro La Ferlita, Antonio Di Maria, Venera Cardile, Adriana CE Graziano, Venerando Rapisarda, Caterina Ledda, Alfredo Pulvirenti, and Carla Loreto. “Dysregulation of microRNAs and tRNA-derived ncRNAs in mesothelial and mesothelioma cell lines after asbestiform fiber exposure.” Scientific Reports 12, no. 1 (2022): 1-21. https://www.nature.com/articles/s41598-022-13044-0

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • |

    Mesothelioma Case Shows Danger of Accidental Asbestos Exposure

    A mesothelioma case in Birmingham, England is a dramatic illustration of the very real danger of hidden asbestos. The widow of a physician who died of mesothelioma last year at the age of 51 claims her husband was exposed to asbestos just walking to and from his medical classes. Monisha Coelho believes that exposed asbestos insulation in the underground hallways that connect the University of Birmingham to buildings on the Queen Elizabeth Hospital campus triggered Dr. Ian Pardoe’s mesothelioma. In an article in the Birmingham Mail, Coelho explained how her husband decided how and where the deadly exposure had occurred. “Ian thought long and hard about where he might have come into contact with asbestos,” Coelho told the paper. “He…